Markets:

Overview

News

Currencies

International

Treasuries

Eaton Vance Ohio Municipal Income Trust (NQ:EVO)

3.111 +0.331 (+11.91%)

Streaming Delayed Price Updated: 3:57 PM EDT, Apr 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eaton Vance Ohio Municipal Income Trust

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Pasithea Biotech Reports That It's Aiming To Be At The Forefront Of The Mental Health Revolution ↗

April 25, 2022

Image provided by Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Via Benzinga

24 Biggest Movers From Yesterday ↗

April 13, 2022

Gainers Vertical Aerospace Ltd. (NYSE: EVTL) Shares hiked 30.93% to close at $9.82 on Tuesday after Deutsche Bank initiated coverage of the stock. Peabody Energy Corporation (...

Via Benzinga

The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More ↗

April 12, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

TYME Technologies Reviews Potential Strategic Options ↗

March 29, 2022

Via Benzinga

Earnings Scheduled For May 11, 2022 ↗

May 11, 2022

Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter.

Via Benzinga

Evotec and Bristol Myers Squibb Extend and Expand Strategic Partnership

May 10, 2022

HAMBURG, GERMANY / ACCESSWIRE / May 10, 2022 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE 000 566480 9, WKN 566480; NASDAQ:EVO) announces today that the Company has extended and...

From Evotec AG

Via AccessWire

Evotec and Bristol Myers Squibb Extend and Expand Strategic Partnership in Protein Degradation

May 10, 2022

- 8-YEAR EXTENSION AND EXPANSION OF COLLABORATION TO DEVELOP PIPELINE OF MOLECULAR GLUE DEGRADERS - COLLABORATION LEVERAGES EVOTEC'S PROPRIETARY EVO PANOMICS AND EVO PANHUNTER PLATFORMS COVERING...

From Evotec AG

Via AccessWire

Evotec SE to Announce Results for the First Quarter 2022 on 11 May 2022

May 04, 2022

Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.

From Evotec AG

Via AccessWire

Evotec SE Fiscal Year 2021 Results: 'Setting the Pace' on the Data-Driven R&D Autobahn to Cures

April 12, 2022

- STRONG FINANCIAL RESULTS: 23% INCREASE IN GROUP REVENUES SIGNIFICANTLY EXCEEDING GUIDANCE - DATA-DRIVEN PLATFORMS AND TECHNOLOGIES INCREASE PROBABILITIES OF SUCCESS IN ALL MODALITIES - SUBSTANTIALLY...

From Evotec AG

Via AccessWire

Evotec Achieves Programme Designation in Neuroscience Collaboration with Bristol Myers Squibb

April 08, 2022

- THE PROGRAMME DESIGNATION IS BASED ON AN ANTISENSE-BASED APPROACH WHICH TRIGGERS A US$ 16 M PAYMENT TO EVOTEC BY BRISTOL MYERS SQUIBB - EVOTEC SOURCES LNAPLUS(TM) ANTISENSE TECHNOLOGY THROUGH A...

From Evotec AG

Via AccessWire

Evotec SE to Announce Results for Fiscal Year 2021 on 12 April 2022

April 05, 2022

HAMBURG, GERMANY / ACCESSWIRE / April 5, 2022 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, ISIN: DE0005664809); (NASDAQ:EVO) will announce its financial results for 2021 on Tuesday, 12 April...

From Evotec AG

Via AccessWire

Evotec Receives € 3 m Milestone Payment for Bayer Starting Phase II Clinical Development of DNP Programme

March 21, 2022

- FIRST DOSING OF A STUDY PARTICIPANT TRIGGERS MILESTONE PAYMENT OF € 3 M TO EVOTEC - PHASE II CLINICAL TRIAL INITIATED BY EVOTEC'S PARTNER BAYER TO EVALUATE BAY 2395840 AS A POTENTIAL TREATMENT FOR...

From Evotec AG

Via AccessWire

Evotec Presents Strategic Roadmap Towards Precision Medicine and Confirms Goals of Action Plan 2025 at Capital Markets Day

March 02, 2022

- LAUNCH OF E.MPD, THE LEADING GLOBAL MOLECULAR PATIENT DATABASE - ROLL-OUT AND ACCELERATION OF AI/ML PRECISION TECHNOLOGIES TO INCREASE PROBABILITY OF SUCCESS ("POS") IN RESEARCH, DEVELOPMENT, AND...

From Evotec AG

Via AccessWire

Topics Artificial Intelligence

Evotec Expands Molecular Patient Database with Unique Nephrotic Syndrome Cohort from the University of Bristol

March 01, 2022

- EVOTEC RECEIVES ACCESS TO AN INTERNATIONAL COHORT OF NEPHROTIC SYNDROME PATIENTS COORDINATED BY THE UNIVERSITY OF BRISTOL - THE COHORT PROVIDES LONGITUDINAL ACCESS NOT ONLY TO CLINICAL DATA BUT IN...

From Evotec AG

Via AccessWire

Why Are Evotec Shares Trading Lower On Friday? ↗

February 04, 2022

Bayer AG (OTC: BAYRY) has

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

February 04, 2022

Gainers iRadimed (NASDAQ:IRMD) stock rose 15.0% to $45.19 during Friday's regular session. Trading volume for iRadimed's stock is 94.1K as of 12:30 EST. This is...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

February 07, 2022

On Monday, 71 stocks hit new 52-week lows. Noteable 52-Week Lows: 3M (NYSE:MMM) was the biggest company in terms of market cap to set a new 52-week low. OceanPal (...

Via Benzinga

Bayer Discontinues Clinical Development Candidate Eliapixant (BAY1817080), Evotec Regains the Rights to all P2X3 Assets

February 04, 2022

HAMBURG, GERMANY / ACCESSWIRE / February 4, 2022 / Evotec SE (Frankfurt Stock Exchange, MDAX/TecDAX, ISIN: DE 000 566480 9, WKN 566480; NASDAQ) announces today that the Company has been informed by...

From Evotec AG

Via AccessWire

50 Biggest Movers From Friday ↗

February 07, 2022

Also check out this: Executives Sell Over $45M Of 5 Stocks Losers Ra Medical Systems, Inc. (NYSE: RMED) shares dipped 48.8% to close at $0.3599 on Friday after the...

Via Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data ↗

January 25, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Pfizer, BioNTech Initiates Study Of Omicron-Based Vaccine Candidate Pfizer,...

Via Benzinga

Evotec Enters iPSC-based Drug Discovery Partnership with Boehringer Ingelheim in Ophthalmology

January 25, 2022

- PARTNERSHIP LEVERAGES EVOTEC'S HUMAN IPSC-BASED PHENOTYPIC SCREENING AND PANOMICS PLATFORMS - AIM IS TO IDENTIFY AND VALIDATE PROMISING TARGETS AND NEW APPROACHES FOR THERAPEUTIC INTERVENTIONS...

From Evotec AG

Via AccessWire

Evotec and Lilly Enter into Drug Discovery Collaboration in Metabolic Diseases

January 18, 2022

- COLLABORATION LEVERAGES EVOTEC'S BROAD METABOLIC EXPERTISE AND UNIQUE KIDNEY DISEASE PATIENT DATABASE AS WELL AS INTEGRATED DATA-DRIVEN DRUG DISCOVERY AND DEVELOPMENT PLATFORMS - LILLY HAS THE RIGHT...

From Evotec AG

Via AccessWire

From Mobile Clinics to Drug Development, This Company Is Attempting to Tackle Brain Disorders and Promote Mental Health Advances ↗

January 05, 2022

Photo by David Matos on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...

Via Benzinga

Maravai Lifesciences Stock Closes In Technical Benchmark, Hitting 80-Plus RS Rating ↗

January 03, 2022

One key metric to look for in a stock is 80-plus RS Rating. Maravai Lifesciences stock just hit that mark, with a jump from 71 to 81 Monday.

Via Investor's Business Daily

Evotec Receives € 7.5 m Grant for Development of COVID-19 Therapeutic

January 03, 2022

- EVOTEC RECEIVES A € 7.5 M GRANT FROM THE GERMAN FEDERAL MINISTRY OF EDUCATION AND RESEARCH ("BMBF") FOR THE DEVELOPMENT OF A THERAPEUTIC AGAINST COVID-19 - EVOTEC IS DEVELOPING A HIGHLY POTENT...

From Evotec AG

Via AccessWire

Composite Rating For Regeneron Stock Rises To 96 ↗

December 09, 2021

Regeneron stock saw its IBD SmartSelect Composite Rating rise to 96 Thursday, up from 93 the day before for the New York firm.

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2021 ↗

November 29, 2021

Upgrades According to Odeon Capital, the prior rating for Wells Fargo & Co (NYSE:

Via Benzinga

The Week Ahead In Biotech (Nov. 28-Dec. 4): FDA Decisions For VBI Vaccines, BeyondSpring, CTI Biopharma And Merck Take The Spotlight In A Light Calendar Week ↗

November 28, 2021

Biotech stocks advanced in the week ending Nov. 26, as a late-week surge on the back of news about a new COVID-19 variant, named Omicron, helped mitigate the losses...

Via Benzinga

EXCLUSIVE: This Company Hopes to Take an Innovative Approach To Treat Addiction ↗

November 19, 2021

Photo by Myriam Zilles...

Via Benzinga

EQRx and Evotec Announce Integrated Drug Discovery and Development Partnership

November 18, 2021

From EQRx

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.